CROBM CROBM & JDR Merger
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lerner, U. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lerner, U. H.
15(2):64-81 (2004)     Crit Rev Oral Biol Med
© 2004 International and American Associations for Dental Research

NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION

Ulf H. Lerner

Department of Oral Cell Biology, Umeå University, 901 87 Umeå, Sweden; ulf.lerner{at}odont.umu.se

Osteoclasts are tissue-specific polykaryon bone-resorbing cells derived from the monocyte/macrophage hematopoietic lineage with specialized functions required for the adhesion of the cells to bone and the subsequent polarization of the cell membrane, secretion of acid to dissolve mineral crystals, and release of proteolytic enzymes to degrade the extracellular matrix proteins. Most pathological conditions in the skeleton lead to loss of bone due to excess osteoclastic bone resorption, including periodontal disease, rheumatoid arthritis, and osteoporosis. In rare cases, most of them genetic, patients with osteopetrosis exhibit sclerotic bone due either to a lack of osteoclasts or to non-functional osteoclasts. Mainly because of phenotypic findings in genetically manipulated mice or due to spontaneous mutations in humans, mice, and rats, several genes have been discovered as being crucial for osteoclast formation and activation. Recent breakthroughs in our understanding of osteoclast biology have revealed the critical roles in osteoclast differentiation played by RANKL, RANK, and OPG, three novel members of the tumor necrosis factor ligand and receptor superfamilies. The further study of these molecules and downstream signaling events are likely to provide a molecular basis for the development of new drugs for the treatment of diseases with excess or deficient osteoclastic bone resorption.

Key words. RANKL, OPG, osteoclasts, periodontal disease, osteopetrosis, osteoporosis




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. C. Earp, D. C. DuBois, D. S. Molano, N. A. Pyszczynski, C. E. Keller, R. R. Almon, and W. J. Jusko
Modeling Corticosteroid Effects in a Rat Model of Rheumatoid Arthritis I: Mechanistic Disease Progression Model for the Time Course of Collagen-Induced Arthritis in Lewis Rats
J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 532 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
U.H. Lerner
Bone Remodeling in Post-menopausal Osteoporosis.
J. Dent. Res., July 1, 2006; 85(7): 584 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
U.H. Lerner
Inflammation-induced Bone Remodeling in Periodontal Disease and the Influence of Post-menopausal Osteoporosis.
J. Dent. Res., July 1, 2006; 85(7): 596 - 607.
[Abstract] [Full Text] [PDF]


Home page
FAKE JDRHome page
U.H. Lerner
Bone Remodeling in Post-menopausal Osteoporosis
Journal of Dental Research, July 1, 2006; 85(7): 584 - 595.
[Abstract] [Full Text] [PDF]


Home page
FAKE JDRHome page
U.H. Lerner
Inflammation-induced Bone Remodeling in Periodontal Disease and the Influence of Post-menopausal Osteoporosis
Journal of Dental Research, July 1, 2006; 85(7): 596 - 607.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Swanson, M. Lorentzon, H. H. Conaway, and U. H. Lerner
Glucocorticoid Regulation of Osteoclast Differentiation and Expression of Receptor Activator of Nuclear Factor-{kappa}B (NF-{kappa}B) Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvarial Bones
Endocrinology, July 1, 2006; 147(7): 3613 - 3622.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zheng, X. Yu, P. Collin-Osdoby, and P. Osdoby
RANKL Stimulates Inducible Nitric-oxide Synthase Expression and Nitric Oxide Production in Developing Osteoclasts: AN AUTOCRINE NEGATIVE FEEDBACK MECHANISM TRIGGERED BY RANKL-INDUCED INTERFERON-beta VIA NF-{kappa}B THAT RESTRAINS OSTEOCLASTOGENESIS AND BONE RESORPTION
J. Biol. Chem., June 9, 2006; 281(23): 15809 - 15820.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Palmqvist, P. Lundberg, E. Persson, A. Johansson, I. Lundgren, A. Lie, H. H. Conaway, and U. H. Lerner
Inhibition of Hormone and Cytokine-stimulated Osteoclastogenesis and Bone Resorption by Interleukin-4 and Interleukin-13 Is Associated with Increased Osteoprotegerin and Decreased RANKL and RANK in a STAT6-dependent Pathway
J. Biol. Chem., February 3, 2006; 281(5): 2414 - 2429.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. N. Belibasakis, A. Johansson, Y. Wang, C. Chen, S. Kalfas, and U. H. Lerner
The Cytolethal Distending Toxin Induces Receptor Activator of NF-{kappa}B Ligand Expression in Human Gingival Fibroblasts and Periodontal Ligament Cells
Infect. Immun., January 1, 2005; 73(1): 342 - 351.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Kelk, R. Claesson, L. Hanstrom, U. H. Lerner, S. Kalfas, and A. Johansson
Abundant Secretion of Bioactive Interleukin-1{beta} by Human Macrophages Induced by Actinobacillus actinomycetemcomitans Leukotoxin
Infect. Immun., January 1, 2005; 73(1): 453 - 458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2004 Institutional Access Guidelines